These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 36399689)

  • 21. Attenuation of pathogenic Rift Valley fever virus strain through the chimeric S-segment encoding sandfly fever phlebovirus NSs or a dominant-negative PKR.
    Nishiyama S; Slack OA; Lokugamage N; Hill TE; Juelich TL; Zhang L; Smith JK; Perez D; Gong B; Freiberg AN; Ikegami T
    Virulence; 2016 Nov; 7(8):871-881. PubMed ID: 27248570
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of a recombinant Rift Valley fever virus MP-12 with NSm deletion as a vaccine candidate in sheep.
    Weingartl HM; Nfon CK; Zhang S; Marszal P; Wilson WC; Morrill JC; Bettinger GE; Peters CJ
    Vaccine; 2014 Apr; 32(20):2345-9. PubMed ID: 24462482
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of a novel, single-cycle replicable rift valley Fever vaccine.
    Murakami S; Terasaki K; Ramirez SI; Morrill JC; Makino S
    PLoS Negl Trop Dis; 2014 Mar; 8(3):e2746. PubMed ID: 24651859
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A glycoprotein subunit vaccine elicits a strong Rift Valley fever virus neutralizing antibody response in sheep.
    Faburay B; Lebedev M; McVey DS; Wilson W; Morozov I; Young A; Richt JA
    Vector Borne Zoonotic Dis; 2014 Oct; 14(10):746-56. PubMed ID: 25325319
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunogenicity and efficacy of a chimpanzee adenovirus-vectored Rift Valley fever vaccine in mice.
    Warimwe GM; Lorenzo G; Lopez-Gil E; Reyes-Sandoval A; Cottingham MG; Spencer AJ; Collins KA; Dicks MD; Milicic A; Lall A; Furze J; Turner AV; Hill AV; Brun A; Gilbert SC
    Virol J; 2013 Dec; 10():349. PubMed ID: 24304565
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of Single Amino Acid Changes in the Rift Valley Fever Virus Polymerase Core Domain Contributing to Virus Attenuation
    Borrego B; Moreno S; López-Valiñas Á; de la Losa N; Weber F; Núñez JI; Brun A
    Front Cell Infect Microbiol; 2022; 12():875539. PubMed ID: 35573791
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Recombinant Rift Valley Fever Virus Glycoprotein Subunit Vaccine Confers Full Protection against Rift Valley Fever Challenge in Sheep.
    Faburay B; Wilson WC; Gaudreault NN; Davis AS; Shivanna V; Bawa B; Sunwoo SY; Ma W; Drolet BS; Morozov I; McVey DS; Richt JA
    Sci Rep; 2016 Jun; 6():27719. PubMed ID: 27296136
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The L, M, and S Segments of Rift Valley Fever Virus MP-12 Vaccine Independently Contribute to a Temperature-Sensitive Phenotype.
    Nishiyama S; Lokugamage N; Ikegami T
    J Virol; 2016 Jan; 90(7):3735-44. PubMed ID: 26819307
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk analysis of inter-species reassortment through a Rift Valley fever phlebovirus MP-12 vaccine strain.
    Ly HJ; Lokugamage N; Nishiyama S; Ikegami T
    PLoS One; 2017; 12(9):e0185194. PubMed ID: 28926632
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Study on DNA immune of envelope protein gene of Rift Valley Fever Virus].
    Wang QH; Wang XJ; Hu S; Ge JY; Bu ZG
    Wei Sheng Wu Xue Bao; 2007 Aug; 47(4):677-81. PubMed ID: 17944371
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chimaeric Rift Valley Fever Virus-Like Particle Vaccine Candidate Production in Nicotiana benthamiana.
    Mbewana S; Meyers AE; Rybicki EP
    Biotechnol J; 2019 Apr; 14(4):e1800238. PubMed ID: 30488669
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estimation of the Minimal Rift Valley Fever Virus Protective Neutralizing Antibody Titer in Human Volunteers Immunized with MP-12 Vaccine Based on Protection in a Mouse Model of Disease.
    Watts DM; Westover JLB; Palermo PM; Bailey KW; Morrill JC; Bettinger GE; Monath TP; Smith DR; Peters CJ; Pittman PR; Orbegozo J; Gowen BB
    Am J Trop Med Hyg; 2022 Nov; 107(5):1091-1098. PubMed ID: 36122681
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of Rift Valley fever virus MP-12 strain encoding NSs of Punta Toro virus or sandfly fever Sicilian virus.
    Lihoradova OA; Indran SV; Kalveram B; Lokugamage N; Head JA; Gong B; Tigabu B; Juelich TL; Freiberg AN; Ikegami T
    PLoS Negl Trop Dis; 2013; 7(4):e2181. PubMed ID: 23638202
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunogenicity of a recombinant Rift Valley fever MP-12-NSm deletion vaccine candidate in calves.
    Morrill JC; Laughlin RC; Lokugamage N; Wu J; Pugh R; Kanani P; Adams LG; Makino S; Peters CJ
    Vaccine; 2013 Oct; 31(43):4988-94. PubMed ID: 23994375
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Using RVFV as a Vector Platform for the Expression of Ruminant Disease Antigens.
    Moreno S; Borrego B; Brun A
    Methods Mol Biol; 2022; 2465():209-225. PubMed ID: 35118624
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of three candidate Rift Valley fever vaccines in sheep.
    Kortekaas J; Antonis AF; Kant J; Vloet RP; Vogel A; Oreshkova N; de Boer SM; Bosch BJ; Moormann RJ
    Vaccine; 2012 May; 30(23):3423-9. PubMed ID: 22449427
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and efficacy of a mutagen-attenuated Rift Valley fever virus vaccine in cattle.
    Morrill JC; Mebus CA; Peters CJ
    Am J Vet Res; 1997 Oct; 58(10):1104-9. PubMed ID: 9328662
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Post-exposure vaccination with MP-12 lacking NSs protects mice against lethal Rift Valley fever virus challenge.
    Gowen BB; Bailey KW; Scharton D; Vest Z; Westover JB; Skirpstunas R; Ikegami T
    Antiviral Res; 2013 May; 98(2):135-43. PubMed ID: 23523764
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recombinant Rift Valley fever vaccines induce protective levels of antibody in baboons and resistance to lethal challenge in mice.
    Papin JF; Verardi PH; Jones LA; Monge-Navarro F; Brault AC; Holbrook MR; Worthy MN; Freiberg AN; Yilma TD
    Proc Natl Acad Sci U S A; 2011 Sep; 108(36):14926-31. PubMed ID: 21873194
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The dominant-negative inhibition of double-stranded RNA-dependent protein kinase PKR increases the efficacy of Rift Valley fever virus MP-12 vaccine.
    Lihoradova O; Kalveram B; Indran SV; Lokugamage N; Juelich TL; Hill TE; Tseng CT; Gong B; Fukushi S; Morikawa S; Freiberg AN; Ikegami T
    J Virol; 2012 Jul; 86(14):7650-61. PubMed ID: 22573861
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.